| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.09 | 0.05 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |